Professional Summary
Professional Overview
Giuliano Fratta is a seasoned finance executive with over 15 years of experience in the biosciences and healthcare industries. As the SVP & Chief Financial Officer at AEterna Zentaris Inc., he leverages his deep expertise in financial management, strategic planning, and operational excellence to drive the company's financial growth and performance.
Experience Summary
Current Role
As the SVP & Chief Financial Officer at AEterna Zentaris Inc. since 2022, Giuliano is responsible for overseeing all financial operations, including financial reporting, budgeting, and risk management. He plays a key role in shaping the company's strategic direction, ensuring alignment between financial objectives and overall business goals. Under his leadership, AEterna Zentaris has achieved significant improvements in financial efficiency and profitability.
Career Progression
Prior to his current role, Giuliano served as the Vice President of Finance and Director of Finance at Caprion Biosciences Inc., where he spearheaded the implementation of robust financial systems and processes that contributed to the company's successful growth. Earlier in his career, he held positions as Director of Accounting at IMS Health and Controller at Cato Research, where he honed his skills in financial reporting, regulatory compliance, and strategic decision-making.
Academic Background
Giuliano holds a Bachelor's degree in Accounting from the University of Montreal, where he graduated with distinction. He is a Certified Public Accountant (CPA) and has completed additional training in financial analysis, corporate governance, and leadership development.
Areas of Expertise
- Financial management and reporting
- Strategic planning and budgeting
- Operational optimization and cost control
- Mergers, acquisitions, and integration
- Regulatory compliance and risk management
- Leadership and team development
Professional Impact
Throughout his career, Giuliano has demonstrated a track record of driving financial excellence and operational improvements. At Caprion Biosciences, he played a pivotal role in streamlining financial processes, which resulted in a 20% reduction in operating costs and a 15% increase in profitability. At AEterna Zentaris, he has been instrumental in securing new funding sources and aligning the company's financial strategy with its long-term growth objectives.
Conclusion
With his extensive experience, strong financial acumen, and collaborative leadership style, Giuliano Fratta is well-positioned to continue driving the financial success of AEterna Zentaris Inc. and contributing to the company's growth and innovation in the biosciences industry.
